GSK3B and Parkinson disease: In PD, lithium improves mitochondrial function, reduces ROS, and inhibits GSK-3β. It protects dopaminergic neurons from apoptosis and modulates autophagy, enhancing clearance of damaged proteins and organelles. These effects highlight lithium’s potential as a neuroprotective and disease-modifying therapy, especially in early or prodromal stages.